GLENMARK
Glenmark Pharmaceuticals Limited
Healthcare
Share price
₹2,318
Market cap
₹65,081 Cr
1Y return
▲ 20%
A global research-led pharmaceutical company, Glenmark operates across generics, specialty, and over-the-counter business segments with a presence in more than 80 countries worldwide. The company develops and manufactures pharmaceutical products serving patients across multiple therapeutic areas including oncology, dermatology, and respiratory care. Its distinctive strength lies in combining generic drug manufacturing capabilities with specialty pharmaceutical development and maintaining a robust international distribution network across developed and emerging markets.
Investors holding Glenmark Pharmaceuticals Limited
Latest move
Bandhan Mutual FundExited
Bandhan Mutual Fund has dropped from Glenmark Pharmaceuticals Limited's disclosed shareholder list after previously holding a 1.17 percent stake, indicating either a complete exit or a reduction below the 1 percent disclosure threshold.
Sign in to read more
Whales made 4 more moves in Glenmark Pharmaceuticals Limited
Sign in to see who is buying and selling.
Sign in to find out